Abstract

Whether you are a researcher, a therapist, an enthusiast, or simply curious about psychedelics and their multi-faceted applications: Join us on the opening night of INSIGHT 2023 with a riveting exploration of the field.

Mind-travel with us as we ask questions to the audience and share observations about the rapidly evolving field of psychedelics – and our place in it. Andrea Jungaberle, Sergio Pérez, and Henrik Jungaberle kick-start the conference by exploring the MIND/OVID project and its interwoven relationship with the global field of psychedelics.

The three take a look into the clinic, into research, and the societal implementation of disruptive experiences. How do scientific rigor, therapeutic innovation, and personal transformation converge in 2023?

Together with Gerd Gründer, Andrea Jungaberle, and Sergio Pérez lead the OVID Clinic Berlin. There, they provide safe, evidence-based, and holistic spaces for psychedelic-augmented therapy. Currently, they rebuild their outpatient practice into the first psychedelic day clinic in Europe. What motivates them and what are the challenges they are facing?

Henrik Jungaberle, Director of the MIND Foundation, leads the organization into its eighth year. He talks about the metamorphosis of the teams, projects, and visions – with the psychedelic therapist training APT emerging as the current core.

Discover what’s next – as they travel from skepticism to awe, from the transformative power of psychedelic experience to the challenge of daily integration and implementation. Delve into some of the latest advancements, ethical considerations, and profound possibilities in the world of psychedelics in 2023.